Ignite Creation Date:
2024-05-05 @ 5:13 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00415285
Status:
UNKNOWN
Last Update Posted:
2007-02-13
First Post:
2006-12-20
Brief Title:
Docetaxel Followed by Capecitabine Versus Concomitant DocetaxelCapecitabine for Early Stage Breast Cancer
Sponsor:
Georgia Center for Oncology Research Education
Organization:
Georgia Center for Oncology Research Education
Organization Data
Organization:
Georgia Center for Oncology Research Education
Class:
OTHER
Study ID:
EU822-03
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Georgia Center for Oncology Research Education
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Sanofi | INDUSTRY |